Prefilled Syringes Market, by Type (Conventional Prefilled Syringes and Safety Prefilled Syringes), by Material Type (Glass and Plastic), by Design (Single-chamber, Dual-chamber, and Customized), by End User (Hospitals, Clinics, and Others), and by Region

Prefilled Syringes Market, by Type (Conventional Prefilled Syringes and Safety Prefilled Syringes), by Material Type (Glass and Plastic), by Design (Single-chamber, Dual-chamber, and Customized), by End User (Hospitals, Clinics, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030\

A prefilled syringe is a disposable syringe that is supplied with the substance to be injected. Prefilled syringes are recognized as a reliable, efficient, and convenient method for drug administration. Furthermore, the ease with which many types of injectable medications can be self-administered by the patients makes prefilled syringes a practical method of drug delivery. Prefilled syringes improve patient safety by lowering the risk of unintended needle stick injuries and harmful product exposure that can occur when drawing medication from vials. Prefilled syringes ensure particulate-free solution administration and accommodate quantities ranging from 0.25 to 5.0 ml. As a result, they are best suited to medications that are supplied via subcutaneous or intramuscular injection.

Market Dynamics

The increasing adoption of strategies such as investments by the key players to construct production facilities for prefilled syringes is expected to drive market growth over the forecast period. For instance, in July 2018, Terumo Corporation, one of the world's leading manufacturers of medical devices and supplies, announced that it would invest approximately 7 billion yen (US$ 50 million) to construct an additional production facility at the headquarters plant at Terumo Yamaguchi D&D Corporation, a Terumo Corporation subsidiary, for prefilled syringes.

Moreover, the increasing adoption of strategies such as product launch is expected to drive the market growth over the forecast period. For instance, in December 2018, Terumo Corporation, one of the world's leading manufacturers of medical devices and supplies, announced that Hulio, a biosimilar of Humira, which uses the company's PLAJEX pre-fillable syringe, has launched in Europe. FUJIFILM KYOWA KIRIN BIOLOGICS Co., Ltd., a company engaged in the development and manufacturing of biosimilars, and Terumo Corporation jointly designed the formulation of Hulio. Terumo Yamaguchi D&D Corporation, a wholly-owned subsidiary of Terumo Corporation, would carry the manufacturing on contract, and Mylan N.V., a subsidiary of Viatris Inc., an American global healthcare company, will commercialize the product in Europe.

Key features of the study:

• This report provides an in-depth analysis of the global prefilled syringes market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2022–2030), considering 2021 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global prefilled syringes market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include BD, Gerresheimer AG, SCHOTT AG, West Pharmaceutical Services, Inc., Vetter Pharma International, Stevanato Group, Terumo Corporation, Catalent, Inc., Weigao group, NIPRO PHARMA CORPORATION, Oval Medical Technologies Ltd., and SHL Medical AG
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global prefilled syringes market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts1
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global prefilled syringes market

Detailed Segmentation:

• Global Prefilled Syringes Market, By Type:
• Conventional Prefilled Syringes
• Safety Prefilled Syringes
• Global Prefilled Syringes Market, By Material Type:
• Glass
• Plastic
• Global Prefilled Syringes Market, By Design:
• Single-chamber
• Dual-chamber
• Customized
• Global Prefilled Syringes Market, By End User:
• Hospitals
• Clinics
• Others
• Global Prefilled Syringes Market, By Region:
• North America
• By Country
• U.S.
• Canada
• Latin America
• By Country
• Brazil
• Mexico
• Argentina
• Rest of Latin America
• Europe
• By Country
• Germany
• U.K.
• France
• Italy
• Spain
• Russia
• Rest of Europe
• Asia Pacific
• By Country
• China
• India
• Japan
• Australia
• South Korea
• ASEAN
• Rest of Asia Pacific
• Middle East
• By Country
• GCC
• Israel
• Rest of Middle East
• Africa
• By Region/Country
• South Africa
• Central Africa
• North Africa
• Company Profiles
• BD
• Company Highlights
• Products Portfolio
• Key Highlights
• Financial Performance
• Strategies
• Gerresheimer AG
• SCHOTT AG
• West Pharmaceutical Services, Inc.
• Vetter Pharma International
• Stevanato Group
• Terumo Corporation
• Catalent, Inc
• Weigao group
• NIPRO PHARMA CORPORATION
• Oval Medical Technologies Ltd.
• SHL Medical AG

“*” marked represents similar segmentation in other categories in the respective section.